Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Jun 1;316(Pt 2):593–597. doi: 10.1042/bj3160593

Evidence for specific annexin I-binding proteins on human monocytes.

N J Goulding 1, L Pan 1, K Wardwell 1, V C Guyre 1, P M Guyre 1
PMCID: PMC1217389  PMID: 8687405

Abstract

Recombinant human annexin I and a monoclonal antibody specific for this protein (mAb 1B) were used to investigate surface binding of this member of the annexin family of proteins to peripheral blood monocytes. Flow cytometric analysis demonstrated trypsin-sensitive, saturable binding of annexin I to human peripheral blood monocytes but not to admixed lymphocytes. A monoclonal antibody that blocks the anti-phospholipase activity of annexin I also blocked its binding to monocytes. These findings suggest the presence of specific binding sites on monocytes. Furthermore, surface iodination, immunoprecipitation and SDS/PAGE analysis were used to identify two annexin I-binding proteins on the surface of monocytes with molecular masses of 15 kDa and 18 kDa respectively. The identification and characterization of these annexin I-binding molecules should help us to better understand the specific interactions of annexin I with monocytes that lead to down-regulation of pro-inflammatory cell functions.

Full Text

The Full Text of this article is available as a PDF (424.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bienkowski M. J., Petro M. A., Robinson L. J. Inhibition of thromboxane A synthesis in U937 cells by glucocorticoids. Lack of evidence for lipocortin 1 as the second messenger. J Biol Chem. 1989 Apr 15;264(11):6536–6544. [PubMed] [Google Scholar]
  2. Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Parente L., Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 1980 Sep 11;287(5778):147–149. doi: 10.1038/287147a0. [DOI] [PubMed] [Google Scholar]
  3. Blackwood R. A., Ernst J. D. Characterization of Ca2(+)-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. Biochem J. 1990 Feb 15;266(1):195–200. doi: 10.1042/bj2660195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Christmas P., Callaway J., Fallon J., Jones J., Haigler H. T. Selective secretion of annexin 1, a protein without a signal sequence, by the human prostate gland. J Biol Chem. 1991 Feb 5;266(4):2499–2507. [PubMed] [Google Scholar]
  5. Cirino G., Flower R. J., Browning J. L., Sinclair L. K., Pepinsky R. B. Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung. Nature. 1987 Jul 16;328(6127):270–272. doi: 10.1038/328270a0. [DOI] [PubMed] [Google Scholar]
  6. Cirino G., Peers S. H., Flower R. J., Browning J. L., Pepinsky R. B. Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc Natl Acad Sci U S A. 1989 May;86(9):3428–3432. doi: 10.1073/pnas.86.9.3428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Creutz C. E. The annexins and exocytosis. Science. 1992 Nov 6;258(5084):924–931. doi: 10.1126/science.1439804. [DOI] [PubMed] [Google Scholar]
  8. Davidson F. F., Dennis E. A., Powell M., Glenney J. R., Jr Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J Biol Chem. 1987 Feb 5;262(4):1698–1705. [PubMed] [Google Scholar]
  9. Ernst J. D., Mall A., Chew G. Annexins possess functionally distinguishable Ca2+ and phospholipid binding domains. Biochem Biophys Res Commun. 1994 Apr 29;200(2):867–876. doi: 10.1006/bbrc.1994.1531. [DOI] [PubMed] [Google Scholar]
  10. Fava R. A., McKanna J., Cohen S. Lipocortin I (p35) is abundant in a restricted number of differentiated cell types in adult organs. J Cell Physiol. 1989 Nov;141(2):284–293. doi: 10.1002/jcp.1041410209. [DOI] [PubMed] [Google Scholar]
  11. Ferrante A., Thong Y. H. A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique. J Immunol Methods. 1978;24(3-4):389–393. doi: 10.1016/0022-1759(78)90143-6. [DOI] [PubMed] [Google Scholar]
  12. Flower R. J. Eleventh Gaddum memorial lecture. Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol. 1988 Aug;94(4):987–1015. doi: 10.1111/j.1476-5381.1988.tb11614.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fradin A., Rothhut B., Poincelot-Canton B., Errasfa M., Russo-Marie F. Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'. Biochim Biophys Acta. 1988 Nov 25;963(2):248–257. doi: 10.1016/0005-2760(88)90288-3. [DOI] [PubMed] [Google Scholar]
  14. Goulding N. J., Godolphin J. L., Sharland P. R., Peers S. H., Sampson M., Maddison P. J., Flower R. J. Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet. 1990 Jun 16;335(8703):1416–1418. doi: 10.1016/0140-6736(90)91445-g. [DOI] [PubMed] [Google Scholar]
  15. Goulding N. J., Guyre P. M. Lipocortin 1 binding to human leukocytes correlates with its ability to inhibit IgG interactions with Fc gamma receptors. Biochem Biophys Res Commun. 1993 Apr 30;192(2):351–358. doi: 10.1006/bbrc.1993.1422. [DOI] [PubMed] [Google Scholar]
  16. Goulding N. J., Guyre P. M. Regulation of inflammation by lipocortin 1. Immunol Today. 1992 Aug;13(8):295–297. doi: 10.1016/0167-5699(92)90040-E. [DOI] [PubMed] [Google Scholar]
  17. Goulding N. J., Jefferiss C. M., Pan L., Rigby W. F., Guyre P. M. Specific binding of lipocortin-1 (annexin I) to monocytes and neutrophils is decreased in rheumatoid arthritis. Arthritis Rheum. 1992 Nov;35(11):1395–1397. doi: 10.1002/art.1780351126. [DOI] [PubMed] [Google Scholar]
  18. Goulding N. J., Luying P., Guyre P. M. Characteristics of lipocortin 1 binding to the surface of human peripheral blood leucocytes. Biochem Soc Trans. 1990 Dec;18(6):1237–1238. doi: 10.1042/bst0181237. [DOI] [PubMed] [Google Scholar]
  19. Hayashi H., Owada M. K., Sonobe S., Domae K., Yamanouchi T., Kakunaga T., Kitajima Y., Yaoita H. Monoclonal antibodies specific to a Ca2(+)-bound form of lipocortin I distinguish its Ca2(+)-dependent phospholipid-binding ability from its ability to inhibit phospholipase A2. Biochem J. 1990 Aug 1;269(3):709–715. doi: 10.1042/bj2690709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hirata F., Schiffmann E., Venkatasubramanian K., Salomon D., Axelrod J. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci U S A. 1980 May;77(5):2533–2536. doi: 10.1073/pnas.77.5.2533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hoekstra D., Buist-Arkema R., Klappe K., Reutelingsperger C. P. Interaction of annexins with membranes: the N-terminus as a governing parameter as revealed with a chimeric annexin. Biochemistry. 1993 Dec 28;32(51):14194–14202. doi: 10.1021/bi00214a019. [DOI] [PubMed] [Google Scholar]
  22. Hoffman R. A., Kung P. C., Hansen W. P., Goldstein G. Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4914–4917. doi: 10.1073/pnas.77.8.4914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Homburg C. H., de Haas M., von dem Borne A. E., Verhoeven A. J., Reutelingsperger C. P., Roos D. Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood. 1995 Jan 15;85(2):532–540. [PubMed] [Google Scholar]
  24. Isacke C. M., Lindberg R. A., Hunter T. Synthesis of p36 and p35 is increased when U-937 cells differentiate in culture but expression is not inducible by glucocorticoids. Mol Cell Biol. 1989 Jan;9(1):232–240. doi: 10.1128/mcb.9.1.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kim K. M., Kim D. K., Park Y. M., Kim C. K., Na D. S. Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett. 1994 May 2;343(3):251–255. doi: 10.1016/0014-5793(94)80566-0. [DOI] [PubMed] [Google Scholar]
  26. Klee C. B. Ca2+-dependent phospholipid- (and membrane-) binding proteins. Biochemistry. 1988 Sep 6;27(18):6645–6653. doi: 10.1021/bi00418a001. [DOI] [PubMed] [Google Scholar]
  27. Koopman G., Reutelingsperger C. P., Kuijten G. A., Keehnen R. M., Pals S. T., van Oers M. H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994 Sep 1;84(5):1415–1420. [PubMed] [Google Scholar]
  28. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  29. Le Bouteiller P. P., Mishal Z., Lemonnier F. A., Kourilsky F. M. Quantification by flow cytofluorimetry of HLA class I molecules at the surface of murine cells transformed by cloned HLA genes. J Immunol Methods. 1983 Jul 29;61(3):301–315. doi: 10.1016/0022-1759(83)90224-7. [DOI] [PubMed] [Google Scholar]
  30. Luecke H., Chang B. T., Mailliard W. S., Schlaepfer D. D., Haigler H. T. Crystal structure of the annexin XII hexamer and implications for bilayer insertion. Nature. 1995 Nov 30;378(6556):512–515. doi: 10.1038/378512a0. [DOI] [PubMed] [Google Scholar]
  31. Manjunath R., Graziano R. F., Green W. R. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors. J Immunol. 1986 Mar 15;136(6):2271–2279. [PubMed] [Google Scholar]
  32. Maridonneau-Parini I., Errasfa M., Russo-Marie F. Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages. J Clin Invest. 1989 Jun;83(6):1936–1940. doi: 10.1172/JCI114101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Morganelli P. M., Guyre P. M. IFN-gamma plus glucocorticoids stimulate the expression of a newly identified human mononuclear phagocyte-specific antigen. J Immunol. 1988 Apr 1;140(7):2296–2304. [PubMed] [Google Scholar]
  34. Northup J. K., Valentine-Braun K. A., Johnson L. K., Severson D. L., Hollenberg M. D. Evaluation of the antiinflammatory and phospholipase-inhibitory activity of calpactin II/lipocortin I. J Clin Invest. 1988 Oct;82(4):1347–1352. doi: 10.1172/JCI113737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pepinsky R. B., Sinclair L. K., Chow E. P., O'Brine-Greco B. A dimeric form of lipocortin-1 in human placenta. Biochem J. 1989 Oct 1;263(1):97–103. doi: 10.1042/bj2630097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Pepinsky R. B., Sinclair L. K., Dougas I., Liang C. M., Lawton P., Browning J. L. Monoclonal antibodies to lipocortin-1 as probes for biological function. FEBS Lett. 1990 Feb 26;261(2):247–252. doi: 10.1016/0014-5793(90)80564-y. [DOI] [PubMed] [Google Scholar]
  37. Pepinsky R. B., Tizard R., Mattaliano R. J., Sinclair L. K., Miller G. T., Browning J. L., Chow E. P., Burne C., Huang K. S., Pratt D. Five distinct calcium and phospholipid binding proteins share homology with lipocortin I. J Biol Chem. 1988 Aug 5;263(22):10799–10811. [PubMed] [Google Scholar]
  38. Perretti M., Flower R. J., Goulding N. J. The ability of murine leukocytes to bind lipocortin 1 is lost during acute inflammation. Biochem Biophys Res Commun. 1993 Apr 30;192(2):345–350. doi: 10.1006/bbrc.1993.1421. [DOI] [PubMed] [Google Scholar]
  39. Rao L. V., Tait J. F., Hoang A. D. Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity. Thromb Res. 1992 Sep 1;67(5):517–531. doi: 10.1016/0049-3848(92)90013-z. [DOI] [PubMed] [Google Scholar]
  40. Raynal P., Pollard H. B. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta. 1994 Apr 5;1197(1):63–93. doi: 10.1016/0304-4157(94)90019-1. [DOI] [PubMed] [Google Scholar]
  41. Römisch J., Schüler E., Bastian B., Bürger T., Dunkel F. G., Schwinn A., Hartmann A. A., Pâques E. P. Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction. Blood Coagul Fibrinolysis. 1992 Feb;3(1):11–17. [PubMed] [Google Scholar]
  42. Schlaepfer D. D., Haigler H. T. Characterization of Ca2+-dependent phospholipid binding and phosphorylation of lipocortin I. J Biol Chem. 1987 May 15;262(14):6931–6937. [PubMed] [Google Scholar]
  43. Schlaepfer D. D., Haigler H. T. Expression of annexins as a function of cellular growth state. J Cell Biol. 1990 Jul;111(1):229–238. doi: 10.1083/jcb.111.1.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sen-Majumdar A., Murthy U., Das M. A new trophoblast-derived growth factor from human placenta: purification and receptor identification. Biochemistry. 1986 Feb 11;25(3):627–634. doi: 10.1021/bi00351a017. [DOI] [PubMed] [Google Scholar]
  45. Solito E., Nuti S., Parente L. Dexamethasone-induced translocation of lipocortin (annexin) 1 to the cell membrane of U-937 cells. Br J Pharmacol. 1994 Jun;112(2):347–348. doi: 10.1111/j.1476-5381.1994.tb13075.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Solito E., Raugei G., Melli M., Parente L. Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. FEBS Lett. 1991 Oct 21;291(2):238–244. doi: 10.1016/0014-5793(91)81293-h. [DOI] [PubMed] [Google Scholar]
  47. Strijbos P. J., Hardwick A. J., Relton J. K., Carey F., Rothwell N. J. Inhibition of central actions of cytokines on fever and thermogenesis by lipocortin-1 involves CRF. Am J Physiol. 1992 Oct;263(4 Pt 1):E632–E636. doi: 10.1152/ajpendo.1992.263.4.E632. [DOI] [PubMed] [Google Scholar]
  48. Trotter P. J., Orchard M. A., Walker J. H. Ca2+ concentration during binding determines the manner in which annexin V binds to membranes. Biochem J. 1995 Jun 1;308(Pt 2):591–598. doi: 10.1042/bj3080591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Uemura K., Inagaki H., Wada Y., Nakanishi K., Asai K., Kato T., Ando Y., Kannagi R. Identification of immuno-reactive lipocortin 1-like molecules in serum and plasma by an enzyme immunoassay for lipocortin 1. Biochim Biophys Acta. 1992 Mar 12;1119(3):250–255. doi: 10.1016/0167-4838(92)90210-5. [DOI] [PubMed] [Google Scholar]
  50. Vishwanath B. S., Frey F. J., Bradbury M., Dallman M. F., Frey B. M. Adrenalectomy decreases lipocortin-I messenger ribonucleic acid and tissue protein content in rats. Endocrinology. 1992 Feb;130(2):585–591. doi: 10.1210/endo.130.2.1531128. [DOI] [PubMed] [Google Scholar]
  51. Wallner B. P., Mattaliano R. J., Hession C., Cate R. L., Tizard R., Sinclair L. K., Foeller C., Chow E. P., Browing J. L., Ramachandran K. L. Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature. 1986 Mar 6;320(6057):77–81. doi: 10.1038/320077a0. [DOI] [PubMed] [Google Scholar]
  52. Wang W., Creutz C. E. Role of the amino-terminal domain in regulating interactions of annexin I with membranes: effects of amino-terminal truncation and mutagenesis of the phosphorylation sites. Biochemistry. 1994 Jan 11;33(1):275–282. doi: 10.1021/bi00167a036. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES